Phathom Pharmaceuticals
(NASDAQ:PHAT)
$9.73
0.205[2.15%]
Last update: 12:11PM Get Real Time Here
Q1 2024 Earnings were released on Thu May 9th, before the market open
The most recent conference call was at 8:30 AM, 4 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Phathom Pharmaceuticals Stock (NASDAQ:PHAT), Quotes and News Summary

Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.

Open$9.540
Close-
Volume / Avg.195.829K / 878.212K
Day Range9.400 - 9.999
52 Wk Range6.065 - 17.019
Market Cap$569.547M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
49
Short Interest
42.22%
Days to Cover12.89

Recent News

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
Avi Kapoor
"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), 
Nabaparna Bhattacharya
What's Going On With Phathom Pharmaceuticals Stock?
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo
Adam Eckert
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
3
Feb
5
Mar
6
Apr
6
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PHAT
AVIR

FAQ

Q

How do I buy Phathom Pharmaceuticals (PHAT) stock?

A

You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Phathom Pharmaceuticals's (PHAT) competitors?

A

Other companies in Phathom Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).

Q

What is the target price for Phathom Pharmaceuticals (PHAT) stock?

A

The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Needham on Friday, May 10, 2024. The analyst firm set a price target for 26.00 expecting PHAT to rise to within 12 months (a possible 167.21% upside). 28 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Phathom Pharmaceuticals (PHAT)?

A

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $9.73 last updated Today at May 13, 2024 at 12:11 PM EDT.

Q

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

A

There are no upcoming dividends for Phathom Pharmaceuticals.

Q

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

A

Phathom Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is Phathom Pharmaceuticals (PHAT) going to split?

A

There is no upcoming split for Phathom Pharmaceuticals.

Q

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

A

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch